Publications by authors named "Christopher Ehmann"

Claim this Profile
S
Safety and feasibility of intermediate-dose post-transplant cyclophosphamide for graft-versus-host disease prophylaxis.
Natasha Venugopal, Andrew McGowan, Yoshitaka Inoue, Hong Zheng, Joseph Cioccio, Christopher Ehmann

Ann Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.
Claudia Mae Velasco, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Christopher Ehmann

Br J Haematol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism.
Ruoheng Zhang, Yimeng Shang, Joseph Cioccio, Kevin Rakszawski, Myles Nickolich, Christopher Ehmann

J Mol Diagn· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
Jeffrey J Pu, Kristin N Berger, Chunlei Zheng, Nhan Do, David F Claxton, W Christopher Ehmann

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent disease after a matched sibling hematopoietic transplant in an aplastic anemia patient with a disease risk allele, HLA-B*40:02.
Akshita Khosla, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Christopher Ehmann

Blood Transfus· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.
Emma Zulch, Yoshitaka Inoue, Joseph Cioccio, Kevin Rakszawski, Natthapol Songdej, Christopher Ehmann

Leuk Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model.
Bei Jia, Chenchen Zhao, Kentaro Minagawa, Hiroko Shike, David F Claxton, W Christopher Ehmann

J Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD26PD-1 CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia.
Huarong Zhou, Bei Jia, Charyguly Annageldiyev, Kentaro Minagawa, Chenchen Zhao, W Christopher Ehmann

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis.
Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik, Christopher Ehmann

Ann Hematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients.
Melanie Potiaumpai, Kathryn H Schmitz, Shin Mineishi, Seema Naik, Baldeep Wirk, W Christopher Ehmann

BMJ Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide.
Neal Shah, Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Christopher Ehmann

Leuk Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-myeloablative allogeneic stem cell transplant with fludarabine and reduced dose cyclophosphamide in acute myeloid leukemia for older adults with comorbidities.
Christopher J Pizzola, Joseph Cioccio, Kevin L Rakszawski, Myles Nickolich, W Christopher Ehmann

Bone Marrow Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant cyclophosphamide alters immune signatures and leads to impaired T cell reconstitution in allogeneic hematopoietic stem cell transplant.
Chenchen Zhao, Matthew Bartock, Bei Jia, Neal Shah, David F Claxton, W Christopher C Ehmann

J Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel clinically relevant graft-versus-leukemia model in humanized mice.
Bei Jia, Chenchen Zhao, Michael Bayerl, Hiroko Shike, David F Claxton, W Christopher Ehmann

J Leukoc Biol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion.
Neal Shah, Kevin Rakszawski, Myles Nickolich, Christopher Ehmann, Baldeep Wirk

Ann Hematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia.
Hong Zheng, Shin Mineishi, David Claxton, Junjia Zhu, Chenchen Zhao, W Christopher Ehmann

Am J Hematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected Short-Tandem-Repeat Patterns in Posttransplant Chimerism Testing: Investigation of 3 Cases with Help from Forensic Science.
Kristina Gvozdjan, Heather Casey, Carrie Mowery, Lorie Kumer, Carolyn Fisher, Christopher Ehmann

Lab Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML.
Chenchen Zhao, Bei Jia, Ming Wang, Todd D Schell, David F Claxton, W Christopher Ehmann

Br J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.
Stephen E Spurgeon, Kamal Sharma, David F Claxton, Christopher Ehmann, Jeffrey Pu

Br J Haematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EomesT-bet CD8 T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia.
Bei Jia, Chenchen Zhao, Kevin L Rakszawski, David F Claxton, W Christopher Ehmann

Cancer Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML.
Liru Wang, Bei Jia, David F Claxton, W Christopher Ehmann, Witold B Rybka

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients.
Bei Jia, Liru Wang, David F Claxton, W Christopher Ehmann, Witold B Rybka

Blood Cancer J· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
Liuluan Zhu, Yaxian Kong, Jianhong Zhang, David F Claxton, W Christopher Ehmann

J Hematol Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features.
Emmanuel K Teye, Abigail Sido, Ping Xin, Niklas K Finnberg, Prashanth Gokare, W Christopher Ehmann

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy.
Andre Goy, Andres Forero, Nina Wagner-Johnston, W Christopher Ehmann, Michaela Tsai

Br J Haematol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis